Emergency Pharmacy Medicine Conference
SATURDAY, JANUARY 24, 2026
Stroke of Genius: Mastering the Management of Acute Ischemic and Hemorrhagic Stroke
8:00-9:30am: 1.5 CEUs C/G/T
Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP, Assistant Professor, Pharmacy Practice
Nova Southeastern University College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Describe the pharmacologic management of acute ischemic and hemorrhage stroke; Compare and contrast thrombolytics for the management of acute ischemic stroke; Recommend appropriate treatment modalities for elevated intracranial hypertension, seizure prophylaxis, and antithrombotic reversal; Review guideline recommendations and literature for acute stroke management.
UAN: 0675-0000-26-001-L01-P*
Upon completion of this activity, technicians will be able to: Define acute ischemic and hemorrhage stroke; Identify risk factors for stroke; Compare and contrast thrombolytics for the management of acute ischemic stroke.
UAN: 0675-0000-26-001-L01-T*
A Sticky Situation: A Review of Sickle Cell Disease
9:30-11:00am: 1.5 CEUs C/G/T
Taylor Bunn PharmD, Pain Management and Palliative Care PGY-2 Resident, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Define sickle cell disease and associated complications; Discuss the historical identification of the disease; Evaluate available therapy options used to treat SCD; Discuss and appreciate the use of gene therapy as a cure.
UAN: 0675-0000-26-010-L01-P
Upon completion of this activity, technicians will be able to: Define sickle cell disease and associated complications; Discuss the historical identification of the disease; Evaluate available therapy options used to treat SCD; Discuss and appreciate the use of gene therapy as a cure.
UAN: 0675-0000-26-010-L01-T
Turning the Tide: The Opioid Crisis and Evidence-Based Management of Overdose in the ED
11:15-12:45pm: 1.5 CEUs C/G/T
Joseph Cammilleri, Pharm.D,. BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management PGY2 Pain and Palliative Care Program Director, UF Clinical Assistant Professor, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Describe current trends in opioid use; Recognize the clinical spectrum of opioid toxicity, including atypical presentations and mixed overdoses; Implement evidence-based naloxone dosing strategies, routes of administration, and escalation pathways; Differentiate short-acting versus long-acting opioid exposures to guide monitoring duration and disposition; Initiate ED-based harm reduction, including take-home naloxone, brief counseling, and linkage to community resources; Start or facilitate medication for opioid use disorder in the ED and arrange rapid follow-up.
UAN: 0675-0000-26-003-L08-P*
Upon completion of this activity, technicians will be able to: Describe current trends in opioid use; Recognize the clinical spectrum of opioid toxicity; Use naloxone in emergency situations; Schedule follow-up with patients.
UAN: 0675-0000-26-003-L08-T*
Toxic Trends: Tots to Teens
12:45-1:45pm: 1 CEU C/G/T
Dawn R. Sollee, Pharm.D., DABAT, FAACT, Director, Florida/USVI Poison Information Center- Jacksonville, UF Health Jacksonville Professor, University of Florida College of Medicine, Dept. of Emergency Medicine and UF College of Pharmacy, Clinical Toxicology Fellowship Director
Upon completion of this activity, pharmacists will be able to: Describe the role of poison centers in the United States; Identify medications and household toxins that have a narrow therapeutic index in the pediatric population; Examine recent trends in adolescent suicide attempts and the management of commonly used agents; Review the general approach and management of the poisoned patient.
UAN: 0675-0000-26-004-L01-P*
Upon completion of this activity, technicians will be able to: Describe the role of poison centers in the United States; Identify medications and household toxins that have a narrow therapeutic index in the pediatric population; Examine recent trends in adolescent suicide attempts and the management of commonly used agents.
UAN: 0675-0000-26-004-L01-T
Snakebite Season: Having a Management Plan
1:45-2:15pm: 0.5 CEU C/G/T
Dawn R. Sollee, Pharm.D., DABAT, FAACT, Director, Florida/USVI Poison Information Center- Jacksonville, UF Health Jacksonville Professor, University of Florida College of Medicine, Dept. of Emergency Medicine and UF College of Pharmacy, Clinical Toxicology Fellowship Director
Upon completion of this activity, pharmacists will be able to: Describe the venomous snakes in Florida; Create a management plan for the snake envenomated patient; Evaluate whether antivenom therapy is needed.
UAN: 0675-0000-26-005-L01-P*
Upon completion of this activity, technicians will be able to: Describe the venomous snakes in Florida; Create a management plan for the snake envenomated patient; Evaluate whether antivenom therapy is needed.
UAN: 0675-0000-26-005-L01-T*
C = Consultant CPE G = General Pharmacist CPE T = Technician CPE
No Comments